good luck to cor longs
i've been out of cor for about 2 years.
i lost $150,000 on cor. i'm not blaming anyone but myself for my substantial loss. i drank the cool-aid. i listened to the many voices promoting cor. and i believed ampakine was the cure for a multitude of aliments from head to toe.
after the pps fell overnight to $1 on fda rejection, there was a never ending stream of would-a, could-a, should-a and new indications and trials. and if i remember correctly Rod. & Renshaw stating the pps could be $0.35 received a lot of criticism.
it was always one more indication and one more trial that would put cor back on an upward path.
every once in a while i check the posts. in some ways there the same thing over and over, except that the pps was $0.60 when i got out and now it's $0.20. there seems less discussion about amakine indications and on-going trials, and more about the mismanagement of the company and share dilution.
speaking of dilution, well actually more like "delusion", the reason i check in every now and then is because i want to find a reason to justify getting back in so a can recoup some of my losses. yes, i know that not very realistic, but it's hard to accept that i lost so very much money on cor.
what's the latest and greatest with ampakine drugs/trials. judging by the pps, it doesn't look like there's anyone that thinks it has promse for any indication. and as i stated, the last 75 or so post i read are mostly about management, pipes and additional share authorizations, and not about the science of ampakines.
i hope cor makes big come back.
gook luck
Market Data 
Markets 
AI
